EX-99 2 a17-11095_1ex99.htm EX-99

Exhibit 99

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them of such a statement on Schedule 13G with respect to the Common Shares beneficially owned by each of them of Merus N.V.  This Joint Filing Agreement shall be included as an Exhibit to such Schedule 13G.

 

IN WITNESS WHEREOF, the undersigned hereby execute this Joint Filing Agreement as of the 7th day of April, 2017.

 

 

 

Novartis Bioventures Ltd.

 

 

 

/s/ H.S. Zivi

 

Name: H.S. Zivi

 

Title: Chairman

 

 

 

 

 

/s/ Laurieann Chaikowsky

 

Name: Laurieann Chaikowsky

 

Title: Authorised Signatory

 

 

 

 

 

Novartis AG

 

 

 

/s/ H.S. Zivi

 

Name: H.S. Zivi

 

Title: Chairman

 

 

 

 

 

/s/ Laurieann Chaikowsky

 

Name: Laurieann Chaikowsky

 

Title: Authorised Signatory